Patents by Inventor David Gray Streeter

David Gray Streeter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6858714
    Abstract: The invention provides a human cyclic GMP phosphodiesterase (PDE9A) and polynucleotides which identify and encode PDE9A. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PDE9A.
    Type: Grant
    Filed: March 8, 2001
    Date of Patent: February 22, 2005
    Assignee: Incyte Corporation
    Inventors: Douglas A. Fisher, Douglas H. Gooding, David Gray Streeter
  • Publication number: 20020007046
    Abstract: The invention provides a human cyclic GMP phosphodiesterase (PDE9A) and polynucleotides which identify and encode PDE9A. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PDE9A.
    Type: Application
    Filed: March 8, 2001
    Publication date: January 17, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Douglas A. Fisher, Douglas H. Gooding, David Gray Streeter
  • Patent number: 6255456
    Abstract: The invention provides a human cyclic GMP phosphodiesterase (PDE9A) and polynucleotides which identify and encode PDE9A. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PDE9A.
    Type: Grant
    Filed: January 29, 1999
    Date of Patent: July 3, 2001
    Assignee: Incyte Genomics, Inc.
    Inventors: Douglas A. Fisher, Douglas H. Gooding, David Gray Streeter
  • Patent number: 6083704
    Abstract: The present invention provides a human cytochrome b5 (HCB5) and polynucleotides which encode HCB5. The invention also provides genetically engineered expression vectors and host cells and a method for producing HCBS. The invention also provides for agonists, antisense molecules, antibodies, or antagonists of HCB5, and their use in the prevention and treatment of diseases associated with expression of HCB5. The invention also provides a method for detecting polynucleotides which encode HCB5.
    Type: Grant
    Filed: October 26, 1998
    Date of Patent: July 4, 2000
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Surya K. Goli, David Gray Streeter
  • Patent number: 5922595
    Abstract: The invention provides a human cyclic GMP phosphodiesterase (PDE9A) and polynucleotides which identify and encode PDE9A. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PDE9A.
    Type: Grant
    Filed: December 9, 1997
    Date of Patent: July 13, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Douglas A. Fisher, Douglas H. Gooding, David Gray Streeter
  • Patent number: 5831018
    Abstract: The present invention provides a human cytochrome b5 (HCB5) and polynucleotides which encode HCB5. The invention also provides genetically engineered expression vectors and host cells and a method for producing HCB5. The invention also provides for agonists, antisense molecules, antibodies, or antagonists of HCB5, and their use in the prevention and treatment of diseases associated with expression of HCB5. The invention also provides a method for detecting polynucleotides which encode HCB5.
    Type: Grant
    Filed: February 18, 1997
    Date of Patent: November 3, 1998
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Surya K. Goli, David Gray Streeter